Abstract: A deflector mounts a carbon scrubber element at an atmospheric port of an evaporative emissions canister. A substantially cylindrical shell has an open end and a closed end. A spacer plate extends outwardly from the shell. An elastomeric ring is overmolded within the shell at a longitudinal position between the ends. The elastomeric ring has an inner diameter configured to sealingly receive the carbon element. A plurality of vapor apertures are formed in the shell between the spacer plate and the elastomeric ring. A plurality of elastomeric ribs are overmolded by the interior surface within the shell the vapor apertures and the closed end, and are configured to be spaced around the carbon element to suspend the carbon element spaced away from the shell without blocking a gaseous flow from the vapor vents to the carbon element.

Abstract: A deflector mounts a carbon scrubber element at an atmospheric port of an evaporative emissions canister. A substantially cylindrical shell has an open end and a closed end. A spacer plate extends outwardly from the shell. An elastomeric ring is overmolded within the shell at a longitudinal position between the ends. The elastomeric ring has an inner diameter configured to sealingly receive the carbon element. A plurality of vapor apertures are formed in the shell between the spacer plate and the elastomeric ring. A plurality of elastomeric ribs are overmolded by the interior surface within the shell the vapor apertures and the closed end, and are configured to be spaced around the carbon element to suspend the carbon element spaced away from the shell without blocking a gaseous flow from the vapor vents to the carbon element.

Abstract: A method of treating autism using a probiotic composition including the bacilli (1) Bacillus subtilis, (2) Bacillus coagulans, and (3) Enterococcus faecium. The composition may further include a carrier medium, such as fructo-oligo-saccharides (FOS), as incorporated in a dose form such as a pill, capsule, powder or sachet. The compositions of the invention may be usefully employed as health or nutritional supplements, food additives, or therapeutic agents for combating a wide variety of physiological disorders.

Abstract: A probiotic composition including the bacilli (1) Bacillus subtilis, (2) Bacillus coagulans, and (3) Enterococcus faecium. The composition may further include a carrier medium, such as fructo-oligo-saccharides (FOS), as incorporated in a dose form such as a pill, capsule, powder or sachet. The compositions of the invention may be usefully employed as health or nutritional supplements, food additives, or therapeutic agents for combating a wide variety of physiological disorders, such as irritable bowel syndrome, autism, and fibromyalgia.

Abstract: A method of treating irritable bowel syndrome using a probiotic composition including the bacilli (1) Bacillus subtilis, (2) Bacillus coagulans, and (3) Enterococcus faecium. The composition may further include a carrier medium, such as fructo-oligo-saccharides (FOS), as incorporated in a dose form such as a pill, capsule, powder or sachet. The compositions of the invention may be usefully employed as health or nutritional supplements, food additives, or therapeutic agents for combating a wide variety of physiological disorders.

Abstract: A method for treatment or prophylaxis of a bipolar disorder disease state, by administration of an anti-fungal composition that includes at least one of the bacilli (1) Bacillus subtilis, (2) Bacillus coagulans, and (3) Enterococcus faecium.

Abstract: A method for treatment or prophylaxis of a disease state or other physiological condition, e.g., autism, delayed development, acid reflux disease, vaginal yeast infections, impaired hearing, chronic ear infections, seasonal allergies, Fibromyalgia syndrome, Crohn's disease, colitis, irritable bowel syndrome, interstitial cystitis, acne, sinusitis, rheumatoid arthritis, chronic fatigue syndrome, asthma, attention deficit disorder, attention deficit/hyperactivity disorder, rosacea, multiple sclerosis, hyperglycemia, or Ménière's disease, by administration of an anti-fungal composition that includes at least one of the bacilli (1) Bacillus subtilis, (2) Lactobacillus sporogenes, and (3) Streptococcus faecalis.